ICU
SeaStar Medical Holding CorporationNASDAQHealthcare$4.31+6.26%ClosedMarket Cap: $12.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
9.12
P/S
10.35
EV/EBITDA
-0.11
DCF Value
$4.00
FCF Yield
-106.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
95.7%
Operating Margin
-986.6%
Net Margin
-984.6%
ROE
-188.5%
ROA
-85.8%
ROIC
-111.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $420.0K | 97.1% | $-3.0M | $-2.9M | $-0.80 | — |
| FY 2025 | $1.2M | 95.7% | $-12.2M | $-12.2M | $-5.86 | — |
| Q3 2025 | $183.0K | 92.3% | $-3.6M | $-3.5M | $-1.30 | — |
| Q2 2025 | $338.0K | 92.0% | $-1.8M | $-2.0M | $-1.10 | — |
| Q1 2025 | $293.0K | 100.0% | $-3.8M | $-3.8M | $-4.40 | — |
| Q4 2024 | $67.0K | 100.0% | $-4.8M | $-4.4M | $-9.00 | — |
| FY 2024 | $135.0K | 100.0% | $-17.8M | $-24.8M | $-66.30 | — |
| Q3 2024 | $68.0K | 100.0% | $-4.5M | $-4.5M | $-11.00 | — |
| Q2 2024 | $0.00 | NaN% | $-4.7M | $-3.2M | $-10.26 | — |
| Q1 2024 | $0.00 | NaN% | $-4.0M | $-12.7M | $-47.30 | — |
| Q4 2023 | $0.00 | NaN% | $-2.9M | $-9.9M | $-51.85 | — |
| FY 2023 | $0.00 | NaN% | $-14.2M | $-26.2M | $-302.62 | — |